Rajiv Agarwal

  • 12204 Citations
  • 59 h-Index
1976 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Rajiv Agarwal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
Chronic Renal Insufficiency Medicine & Life Sciences
Blood Pressure Medicine & Life Sciences
Renal Dialysis Medicine & Life Sciences
Hypertension Medicine & Life Sciences
Dialysis Medicine & Life Sciences
Ambulatory Blood Pressure Monitoring Medicine & Life Sciences
Kidney Medicine & Life Sciences
Chronic Kidney Failure Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants 1976 2020

Chlorthalidone
Chronic Renal Insufficiency
Sodium Chloride Symporter Inhibitors
Blood Pressure
Thiazides
Masked Hypertension
Chronic Renal Insufficiency
White Coat Hypertension
Hypertension
Meta-Analysis
Kidney Diseases
Iron
Glomerular Filtration Rate
Chronic Renal Insufficiency
Albuminuria
Renal Dialysis
Hypertension
Ultrafiltration
Left Ventricular Hypertrophy
Dialysis

Publications 1992 2019

Ambulatory Blood Pressure Reduction With SGLT-2 Inhibitors: Dose-Response Meta-analysis and Comparative Evaluation With Low-Dose Hydrochlorothiazide

Georgianos, P. I. & Agarwal, R., Apr 1 2019, In : Diabetes care. 42, 4, p. 693-700 8 p.

Research output: Contribution to journalReview article

Sodium-Glucose Transport Proteins
Hydrochlorothiazide
Meta-Analysis
Blood Pressure
Randomized Controlled Trials
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Chronic Kidney Failure
Longitudinal Studies
Cohort Studies

Assessment and management of hypertension among patients on peritoneal dialysis

Vaios, V., Georgianos, P. I., Liakopoulos, V. & Agarwal, R., Feb 7 2019, In : Clinical Journal of the American Society of Nephrology. 14, 2, p. 297-305 9 p.

Research output: Contribution to journalArticle

Peritoneal Dialysis
Hypertension
Renal Dialysis
Dietary Sodium
Renal Replacement Therapy
1 Citation (Scopus)

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

Mahaffey, K. W., Jardine, M. J., Bompoint, S., Cannon, C. P., Neal, B., Heerspink, H. J. L., Charytan, D. M., Edwards, R., Agarwal, R., Bakris, G., Bull, S., Capuano, G., de Zeeuw, D., Greene, T., Levin, A., Pollock, C., Sun, T., Wheeler, D. C., Yavin, Y., Zhang, H. & 4 others, Zinman, B., Rosenthal, N., Brenner, B. M. & Perkovic, V., Aug 27 2019, In : Circulation. 140, 9, p. 739-750 12 p.

Research output: Contribution to journalArticle

Open Access
Secondary Prevention
Chronic Renal Insufficiency
Type 2 Diabetes Mellitus
Kidney
Primary Prevention
29 Citations (Scopus)

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

for the CREDENCE Trial Investigators, Jun 13 2019, In : New England Journal of Medicine. 380, 24, p. 2295-2306 12 p.

Research output: Contribution to journalArticle

Type 2 Diabetes Mellitus
Kidney
Confidence Intervals
Chronic Kidney Failure
Placebos